Funding for this research was provided by:
National Institute on Drug Abuse (R56-DA044210, T32-DA043469)
University of Chicago, Department of Psychiatry and Behavioral Neuroscience (Research Faculty Fund)
Article History
Received: 29 June 2018
Accepted: 13 February 2019
First Online: 22 February 2019
Compliance with ethical standards
: The study was fully approved by the University of Chicago Institutional Review Board.
: Dr. King has received funding from the National Institutes of Health and from Pfizer, Inc., has provided past consultation to Lundbeck and the US Food and Drug Administration, and has served on a health advisory board to Pfizer Inc. Dr. Cao has provided consultation to the US Food and Drug Administration. AV and MH have no conflicts of interest to declare.